Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/9936
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kloprogge, S | en |
dc.contributor.author | Kowal, L | en |
dc.contributor.author | Wall, J | en |
dc.contributor.author | Frauman, Albert G | en |
dc.date.accessioned | 2015-05-15T23:13:34Z | |
dc.date.available | 2015-05-15T23:13:34Z | |
dc.date.issued | 2005-05-06 | en |
dc.identifier.citation | European Journal of Ophthalmology; 15(3): 315-23 | en |
dc.identifier.govdoc | 15944998 | en |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/9936 | en |
dc.description.abstract | Graves' ophthalmopathy (GO) is a controversial disease, with disagreement within the medical community regarding its pathogenesis, diagnosis, and treatment.We reviewed recent literature on clinical and pathological aspects of GO from both the endocrinologist's and ophthalmologist's perspective.Investigations into the pathogenesis of GO have included possible antigenic targets, orbital cell types, and development of animal models. Diagnosis has been improved recently with new tools and grading systems, but can be complicated by conditions that may simulate one or more of the findings of GO. The new findings of clinical studies also compel practitioners to reassess commonly used GO treatments such as orbital irradiation.Improved understanding of the pathogenic mechanisms of GO should hopefully lead to new diagnostic and therapeutic approaches to this problematic condition. | en |
dc.language.iso | en | en |
dc.subject.other | Animals | en |
dc.subject.other | Disease Models, Animal | en |
dc.subject.other | Graves Disease.diagnosis.pathology.therapy | en |
dc.subject.other | Humans | en |
dc.title | The clinicopathologic basis of Graves' ophthalmopathy: a review. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | European journal of ophthalmology | en |
dc.identifier.affiliation | Molecular Immunology Lab., Clinical Pharmacology and Therapeutics Unit, Department of Medicine, University of Melbourne, Austin Health, Heildeberg, Victoria, Australia | en |
dc.description.pages | 315-23 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/15944998 | en |
dc.type.austin | Journal Article | en |
local.name.researcher | Frauman, Albert G | |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | No Fulltext | - |
item.openairetype | Journal Article | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Clinical Pharmacology and Therapeutics | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.